You have no items in your shopping cart.
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.89 KDa. Observed: 61 KDa, reducing conditions
Human
Gln19-Ser427
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.09 KDa. Observed: 35-45 KDa, reducing conditions
Human
Val34-Ser240
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39.9 KDa. Observed: 65 KDa, reducing conditions
Human
Ala25-Pro378
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 30.24 KDa. Observed: 37 KDa, reducing conditions
Human
Arg26-Pro281
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.05 KDa. Observed: 28-40 KDa, reducing conditions
Human
Ser27-Ile151
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.37 KDa. Observed: 25-38 KDa, reducing conditions
Human
Ser19-Thr134
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 55.3 KDa. Observed: 60 KDa, reducing conditions
Human
Met1-Gln471
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 45 KDa. Observed: 52 KDa, reducing conditions
Human
Met1-Cys394
N-6His
500 μg, 1 mg, 10 μg, 50 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 26 KDa. Observed: 29 KDa, reducing conditions
Human
Ser2-Arg216
C-6His
10 μg, 50 μg, 500 μg, 1 mgGreater than 80% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 14.83 KDa. Observed: 16 KDa, reducing conditions
Human
Gly237-Ser352
N-6His
10 μg, 50 μg, 500 μg, 1 mg
